Vita Life Sciences Limited (VLS.AX)

AUD 1.78

(0.0%)

Long Term Debt Summary of Vita Life Sciences Limited

Vita Life Sciences Limited's latest annual long term debt in 2023 was 176 Thousand AUD , down -41.53% from previous year.
Vita Life Sciences Limited's latest quarterly long term debt in 2024 Q2 was - AUD , down 0.0% from previous quarter.
Vita Life Sciences Limited reported annual long term debt of 301 Thousand AUD in 2022, up 64.48% from previous year.
Vita Life Sciences Limited reported annual long term debt of 183 Thousand AUD in 2021, down -87.42% from previous year.
Vita Life Sciences Limited reported quarterly long term debt of 176 Thousand AUD for 2023 Q4, down 0.0% from previous quarter.
Vita Life Sciences Limited reported quarterly long term debt of 176 Thousand AUD for 2023 FY, down -41.53% from previous quarter.

Annual Long Term Debt Chart of Vita Life Sciences Limited (2023 - 2007)

Historical Annual Long Term Debt of Vita Life Sciences Limited (2023 - 2007)

Year	Long Term Debt	Long Term Debt Growth
2023	176 Thousand AUD	-41.53%
2022	301 Thousand AUD	64.48%
2021	183 Thousand AUD	-87.42%
2020	1.45 Million AUD	-14.66%
2019	1.7 Million AUD	-1.56%
2018	1.73 Million AUD	-10.12%
2017	1.92 Million AUD	-11.65%
2016	2.18 Million AUD	-15.04%
2015	2.56 Million AUD	-17.03%
2014	3.09 Million AUD	0.0%
2013	- AUD	0.0%
2012	- AUD	0.0%
2011	- AUD	0.0%
2010	- AUD	-100.0%
2009	13.17 Thousand AUD	52.67%
2008	8631.00 AUD	0.0%
2007	- AUD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- AUD	0.0%
2023 Q4	176 Thousand AUD	0.0%
2023 FY	176 Thousand AUD	-41.53%
2023 Q2	198 Thousand AUD	0.0%
2022 Q4	301 Thousand AUD	0.0%
2022 FY	301 Thousand AUD	64.48%
2022 Q2	291 Thousand AUD	0.0%
2021 FY	183 Thousand AUD	-87.42%
2021 Q2	213 Thousand AUD	0.0%
2021 Q4	183 Thousand AUD	0.0%
2020 FY	1.45 Million AUD	-14.66%
2020 Q2	1.27 Million AUD	0.0%
2020 Q4	1.45 Million AUD	0.0%
2019 Q2	1.56 Million AUD	0.0%
2019 FY	1.7 Million AUD	-1.56%
2019 Q4	1.7 Million AUD	0.0%
2018 Q2	1.86 Million AUD	0.0%
2018 FY	1.73 Million AUD	-10.12%
2018 Q4	1.73 Million AUD	0.0%
2017 Q2	1.98 Million AUD	0.0%
2017 Q4	1.92 Million AUD	0.0%
2017 FY	1.92 Million AUD	-11.65%
2016 Q2	2.52 Million AUD	0.0%
2016 FY	2.18 Million AUD	-15.04%
2016 Q4	2.18 Million AUD	0.0%
2015 Q2	2.92 Million AUD	0.0%
2015 Q4	2.56 Million AUD	0.0%
2015 FY	2.56 Million AUD	-17.03%
2014 FY	3.09 Million AUD	0.0%
2014 Q4	3.09 Million AUD	0.0%
2014 Q2	- AUD	0.0%
2013 Q2	- AUD	0.0%
2013 FY	- AUD	0.0%
2013 Q4	- AUD	0.0%
2012 FY	- AUD	0.0%
2012 Q4	- AUD	0.0%
2011 FY	- AUD	0.0%
2011 Q4	- AUD	0.0%
2010 Q4	- AUD	0.0%
2010 FY	- AUD	-100.0%
2009 Q4	13.17 Thousand AUD	0.0%
2009 FY	13.17 Thousand AUD	52.67%
2008 FY	8631.00 AUD	0.0%
2008 Q4	8631.00 AUD	0.0%
2007 FY	- AUD	0.0%

Peer Long Term Debt Comparison of Vita Life Sciences Limited

Name	Long Term Debt	Long Term Debt Difference
Althea Group Holdings Limited	- AUD	-Infinity%
Cann Group Limited	421 Thousand AUD	58.195%
ECS Botanics Holdings Ltd	- AUD	-Infinity%
Ecofibre Limited	9.5 Million AUD	98.147%
Elixinol Wellness Limited	178 Thousand AUD	1.124%
Hygrovest Limited	- AUD	-Infinity%
IDT Australia Limited	- AUD	-Infinity%
Invion Limited	- AUD	-Infinity%
Little Green Pharma Ltd	5.31 Million AUD	96.686%
Live Verdure Ltd	- AUD	-Infinity%
Medical Developments International Limited	1.91 Million AUD	90.809%
Vitura Health Limited	4.11 Million AUD	95.727%